ArticleCancer genomics & proteomics

Serum Exosomes Expressing CD9, CD63 and HER2 From Breast-Cancer Patients Decreased After Surgery of the Primary Tumor: A Potential Biomarker of Tumor Burden.

Sachiko Inubushi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.